Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) will release its second quarter 2026 financial results for the period ended June 30, 2026, on Wednesday, August 5, 2026, after the market close.

The company will host a conference call the same day at 4:30 p.m. EDT, accessible by phone using passcode 4727037 or via live webcast and archived replay in the Investors section of its website.

News Market Reaction – AKBA

-0.79%

7 alerts

-0.79% Session close to close

$367.73M Market Cap

0.5x Rel. Volume

In the Jul 29 session, AKBA declined 0.79%, reflecting a mild negative market reaction. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Historical earnings-date reactions were +1.45% and 0% over 24 hours. That record adds context to thi...

Analysis

Historical earnings-date reactions were +1.45% and 0% over 24 hours. That record adds context to this scheduled Q2 release, while recent insider activity was classified as Net Selling; the eventual results remain the key information to assess.

Key Figures

Reporting period: Q2 2026 Results release date: August 5, 2026 Conference call time: 4:30 p.m. EDT

3 metrics

Reporting period Q2 2026 Financial results for the quarter ended June 30, 2026

Results release date August 5, 2026 Following the close of financial markets

Conference call time 4:30 p.m. EDT August 5, 2026

Previous Earnings date Reports

2 past events · Latest: Apr 30 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 30	earnings date notice	Neutral	+1.4%	Scheduled first-quarter 2026 results release and conference call
Feb 19	earnings date notice	Neutral	+0.0%	Scheduled fourth-quarter and full-year 2025 results release

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date announcements produced nonnegative 24-hour reactions of 1.45% and 0%, with an average move of 0.72%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Akebia to Host Conference Call on August 5 at 4:30 p.m. EDT

CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the second quarter ended June 30, 2026 on Wednesday, August 5, 2026, following the close of the financial markets.

Akebia will host a conference call on Wednesday, August 5, 2026, at 4:30 p.m. EDT to discuss its financial results and recent business highlights. To access the call, please dial (646) 307-1963 or toll-free (800) 715-9871 and enter passcode: 4727037. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

FAQ

When will Akebia Therapeutics (AKBA) report its Q2 2026 financial results?

Akebia Therapeutics will report its Q2 2026 financial results on Wednesday, August 5, 2026, after the market close. According to Akebia, the results cover the quarter ended June 30, 2026, and will be followed by a conference call at 4:30 p.m. EDT.

What time is Akebia Therapeutics (AKBA) Q2 2026 earnings conference call on August 5, 2026?

Akebia Therapeutics will hold its Q2 2026 earnings conference call on August 5, 2026, at 4:30 p.m. EDT. According to Akebia, investors can join by phone using passcode 4727037 or via a live webcast in the Investors section of its website.

How can investors access the Akebia Therapeutics (AKBA) Q2 2026 earnings call?

Investors can access the Akebia Q2 2026 earnings call by dialing (646) 307-1963 or (800) 715-9871 with passcode 4727037. According to Akebia, a live webcast and archived replay will also be available in the Investors section of its website.

Will there be a webcast replay of the Akebia Therapeutics (AKBA) Q2 2026 earnings call?

Yes, Akebia will provide an online archive of the Q2 2026 earnings webcast in the Investors section of its website. According to Akebia, investors can access both the live webcast and replay via the company’s investor relations webpage after the call.

What is the passcode for the Akebia Therapeutics (AKBA) Q2 2026 earnings conference call?

The passcode for Akebia Therapeutics’ Q2 2026 earnings conference call is 4727037. According to Akebia, participants should dial (646) 307-1963 or toll-free (800) 715-9871 and enter this passcode, preferably 15 minutes before the 4:30 p.m. EDT start time.

Where can I find the Akebia Therapeutics (AKBA) investor webcast for Q2 2026 results?

The Akebia Therapeutics Q2 2026 results webcast will be available in the Investors section of Akebia’s website. According to Akebia, both the live webcast and archived replay can be accessed via its investor relations page at the provided IR web address.